Further evidence for the role of ENPP1 in obesity: Association with morbid obesity in Finns

Obesity

Volumn 16, Issue 9, 2008, Pages 2113-2119

  Valli Jaakola, Kaisa ^a   Suviolahti, Elina ^b   Schalin Jäntti, Camilla ^a,c   Ripatti, Samuli ^b,d   Silander, Kaisa ^b   Oksanen, Laura ^a   Salomaa, Veikko ^b   Peltonen, Leena ^a,b,e   Kontula, Kimmo ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE 1; INORGANIC PYROPHOSPHATASE; MELANOCORTIN RECEPTOR; PHOSPHODIESTERASE; PROOPIOMELANOCORTIN;

ALLELE; ARTICLE; FEMALE; FINLAND; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; MALE; MIDDLE AGED; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ALLELES; DIABETES MELLITUS, TYPE 2; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY, MORBID; PHOSPHORIC DIESTER HYDROLASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PRO-OPIOMELANOCORTIN; PYROPHOSPHATASES; RECEPTORS, MELANOCORTIN;

EID: 51049121372     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2008.313     Document Type: Article

References (64)

1. Hossein P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007;356:213-215.
2. Farooqi IS, O'Rahilly S. Monogenic obesity in humans. Annu Rev Med 2005;56:443-458.
3. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-770.
4. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:861-671.
5. Lee YS, Poh LK, Loke KY. A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity. J Clin Endocrinol Metab 2002;87:1423-1428.
6. Tao YX, Segaloff DL. Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation. J Clin Endocrinol Metab 2004;89:3936-3942.
7. Rached M, Buronfosse A, Begeot M, Penhoat A. Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity. Biochim Biophys Acta 2004;1889:229-234.
8. Lee YS, Poh LK, Kek BL, Loke KY. The role of melanocortin 3 receptor gene in childhood obesity. Diabetes 2007;56:2622-2630.
9. Boucher N, Lanouette CM, Larose Metal. A +2138InsCAGACC polymorphism of the melanocortin receptor 3 gene is associated in human with fat level and partitioning in interaction with body corpulence. Mol Med 2002;8:158-185.
10. Schalin-Jäntti C, Valli-Jaakola K, Oksanen L et al. Melanocortin-3-receptor gene variants in morbid obesity. Int J Obes Relat Metab Disord 2003;27:70-74.
11. Borecki IB, Rice T, Perusse L, Bouchard C, Rao DC. An exploratory investigation of genetic linkage with body composition and fatness phenotypes: the Quebec Family Study. Obes Res 1994;2:213-219.
12. Stone S, Abkevich V, Hunt SC et al. A major predisposition locus for severe obesity, at 4p15-p14. Am J Hum Genet 2002;70:1459-1468.
13. Lembertas AV, Perusse L, Chagnon YC et al. Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q. J Clin Invest 1997;1100:1240-1247.
14. Chagnon YC, Chen WJ, Perusse L et al. Linkage and association studies between the melanocortin receptors 4 and 5 genes and obesity-related phenotypes in the Quebec Family Study. Mol Med 1997;3:863-673.
15. Chen W, Li S, Cook NR et al. An autosomal genome scan for loci influencing longitudinal burden of body mass index from childhood to young adulthood in white sibships: The Bogalusa Heart Study. Int J Obes Relat Metab Disord 2004;28:462-469.
16. Prudente S, Trischitta V Editorial: The pleiotropic effect of the ENPP1 (PC-1) gene on insulin resistance, obesity, and type 2 diabetes. J Clin Endocrinol Metab 2006;91:4767-4788.
17. Maddux BA, Goldfine ID. Membrane glycoprotein PC-1 inhibition of insulin receptor function occurs via direct interaction with the receptor a-subunit. Diabetes 2000;49:13-19.
18. Bell CG, Benzinou M, Siddiq A et al. Genome-wide linkage analysis for severe obesity in French caucasians finds significant susceptibility locus on chromosome 19q. Diabetes 2004;53:1857-1885.
19. Meyre D, Lecoeur C, Delplanque J et al. A genome-wide scan for childhood obesity-associated traits in French families shows significant linkage on chromosome 6q22.31-g23.2. Diabetes 2004;53:803-811.
20. Fox CS, Heard-Costa NL, Wilson PW et al. Genome-wide linkage to chromosome 6 for waist circumference in the Framingham Heart Study. Diabetes 2004;53:1399-1402.
21. Arya R, Blangero J, Williams K et al. Factors of insulin resistance syndrome-related phenotypes are linked to genetic locations on chromosomes 8 and 7 in nondiabetic Mexican-Americans. Diabetes 2002;51:841-847.
22. Pizzuti A, Frittitta L, Argiolas A et al. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance. Diabetes 1999;48:1881-1884.
23. Gu HF, Almgren P, Lindholm E et al. Association between the human glycoprotein PC-1 gene and elevated glucose and insulin levels in a paired-sibling analysis. Diabetes 2000;49:1601-1803.
24. Abate N, Carulli L, Cabo-Chan A Jr et al. Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. J Clin Endocrinol Metab 2003;88:5927-5934.
25. Frittitta L, Baratta R, Spampinato D et al. The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance. J Clin Endocrinol Metab 2001;86:5888-5891.
26. Willer CJ, Bonnycastle LL, Conneely KN et al. Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes. Diabetes 2007;56:258-264.
27. Wan C, Zhang T, Wang B et al. Obesity risk associated with the K121Q polymorphism of the glycoprotein PC-1 gene. Diabetes Obes Metab 2006;8:703-708.
28. Barroso I, Luan J, Middelberg RP et al. Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biol 2003;1:E20.
29. Meyre D, Bouatia-Naji N, Tounian A et al. Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes. Nat Genet 2005;37:863-867.
30. Böttcher Y, Körner A, Reinehr T et al. ENPP1 variants and haplotypes predispose to early onset obesity and impaired glucose and insulin metabolism in German obese children. J Clin Endocrinol Metab 2006;91:4948-4952.
31. Costanzo BV, Trischitta V, Di Paola R et al. The Q allele variant (GLN121) of membrane glycoprotein PC-1 interacts with the insulin receptor and inhibits insulin signaling more effectively than the common K allele variant (LYS121). Diabetes 2001;50:831-838.
32. Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W. The K1210 polymorphism of the plasma cell glycoprotein-1 gene is not associated with diabetes mellitus type 2 in German Caucasians. Horm Metab Res 2006;38:524-529.
33. Weedon MN, Shields B, Hitman G et al. No evidence of association of ENPP1 variants with type 2 diabetes or obesity in a study of 8,089 U.K. Caucasians. Diabetes 2008;55:3175-3179.
34. Lyon HN, Florez JC, Bersaglieri T et al. Common variants in the ENPP1 gene are not reproducibly associated with diabetes or obesity. Diabetes 2006;55:3180-3184.
35. Matsuoka N, Patki A, Tiwari HK et al. Association of K1210 polymorphism in ENPP1 (PC-1) with BMI in Caucasian and African-American adults. Int J Obes (Lond) 2008;30:233-237.
36. Chen MP, Chung FM, Chang DM et al. ENPP1 K121Q polymorphism is not related to type 2 diabetes mellitus, features of metabolic syndrome, and diabetic cardiovascular complications in a Chinese population. Rev Diabet Stud 2008;3:21-30.
37. Meyre D, Bouatia-Naji N, Vatin V et al. ENPP1 K121Q polymorphism and obesity, hyperglycaemia and type 2 diabetes in the prospective DESIR Study. Diabetologia 2007;50:2090-2096.
38. Abate N, Chandalia M, Satija P et al. ENPP1/PC-1 K121Q polymorphism and genetic susceptibility to type 2 diabetes. Diabetes 2005;54:1207-1213.
39. Bacci S, Ludovico O, Prudente S et al. The K121Q polymorphism of the ENPP1/PC-1 gene is associated with insulin resistance/atherogenic phenotypes, including earlier onset of type 2 diabetes and myocardial infarction. Diabetes 2005;54:3021-3025.
40. Grarup N, Urhammer SA, Ek J et al. Studies of the relationship between the ENPP1 K121Q polymorphism and type 2 diabetes, insulin resistance and obesity in 7,333 Danish white subjects. Diabetologia 2006;49:2097-2104.
41. Oksanen L, Öhman M, Heiman M et al. Markers for the gene ob and serum leptin levels in human morbid obesity. Hum Genet 1997;99:559-564.
42. Oksanen L, Kainulainen K, Heiman M, Mustajoki P, Kauppinen-Makelin R, Kontula K. Novel polymorphism of the human ob gene promoter in lean and morbidly obese subjects. Int J Obes Relat Metab Disord 1997;21:489-494.
43. Oksanen L, Palvimo JJ, Janne OA, Kontula K. Functional analysis of the C(-188) A polymorphism of the human leptin promoter. Hum Genet 1998;103:527-528.
44. Oksanen L, Kaprio J, Mustajoki P, Kontula K. A common pentanucleotide polymorphism of the 3′-untranslated part of the leptin receptor gene generates a putative stem-loop motif in the mRNA and is associated with serum insulin levels in obese individuals. Int J Obes Relat Metab Disord 1998;22:634-640.
45. Valli-Jaakola K, Lipsanen-Nyman M, Oksanen L et al. Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults. J Clin Endocrinol Metab 2004;89:940-945.
46. Valli-Jaakola K, Palvimo JJ, Upsanen-Nyman M et al. A two-base deletion -439delGC in the melanocortin-4 receptor promoter associated with early-onset obesity. Horm Res 2006;66:61-69.
47. Oksanen L, Mustajoki P, Kaprio J et al. Polymorphism of the β3-adrenergic receptor gene in morbid obesity. Int J Obes Relat Metab Disord 1996;20:1055-1061.
48. Vartiainen E, Jousilahti P, Alfthan G et al. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol 2000;29:49-56.
49. Schwartz S, Zhang Z, Frazer KA et al. PipMaker - a web server for aligning two genomic DNA sequences. Genome Res 2000;10:577-586.
50. Frazer KA, Pachter L, Poliakov A, Rubin EM, Dubchak I. VISTA: computational tools for comparative genomics. Nucleic Acids Res 2004;32:W273-W279.
51. Heinemeyer T, Wingender E, Reuter I et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998;26:362-367.
52. Schug J, Overton CG. TESS: Transcription Element Search Software on the WWW.Technical Report CBIL-TR-1997-1001-v0.0. Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania. 1997.
53. Sandelin A, Wasserman WW, Lenhard B. ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res 2004;32:W249-W252.
54. Berezikov E, Guryev V, Plasterk RH, Cuppen E. CONREAL: conserved regulatory elements anchored alignment algorithm for identification of transcription factor binding sites by phylogenetic footprinting. Genome Res 2004;14:170-178.
55. Raymond M, Rousset F. GENEPOP (version 1.2): population genetics software for exact tests and ecumenicism. J Hered 1995;86:248-249.
56. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
57. Gabriel SB, Schaffner SF, Nguyen H et al. The structure of haplotype blocks in the human genome. Science 2002;296:2225-2229.
58. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B Methodol 1995;57:289-300.
59. Baratta R, Di Paola R, Spampinato D et al. Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms. J Mol Med 2003;81:718-723.
60. Chandalia M, Grundy SM, Adams-Huet B, Abate N. Ethnic differences in the frequency of ENPP1/PC1 121Q genetic variant in the Dallas Heart Study cohort. J Diabetes Complications 2007;21:143-148.
61. Bochenski J, Placha G, Wanic K et al. New polymorphism of ENPP1 (PC-1) is associated with increased risk of type 2 diabetes among obese individuals. Diabetes 2008;55:2626-2630.
62. Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev 2004;58:1-29.
63. Santoro N, del Giudice EM, Cirillo G et al. An insertional polymorphism of the proopiomelanocortin gene is associated with fasting insulin levels in childhood obesity. J Clin Endocrinol Metab 2004;89:4846-4849.
64. Pietinen P, Vartiainen E, Mannisto S. Trends in body mass index and obesity among adults in Finland from 1972 to 1992. Int J Obes Relat Metab Disord 1996;20:114-120.